Palvella Therapeutics, Inc.
PVLA
$120.57
-$5.22-4.15%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -113.56% | -139.27% | -567.01% | -358.04% | -247.37% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 94.40% | 89.97% | 164.54% | 153.75% | 134.38% |
| Change in Net Operating Assets | 373.06% | 2,077.20% | -265.08% | 7.86% | 40.22% |
| Cash from Operations | -76.31% | -130.68% | -223.51% | -146.51% | -53.89% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -65.58% | -43.78% | 268.66% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 285.65% | -98.73% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -321.76% | -116.44% | 5,925.58% | 7,038.89% | -- |
| Cash from Financing | 150.65% | -100.76% | 328.65% | 412.65% | 1,617.74% |
| Foreign Exchange rate Adjustments | 1,333.33% | 1,433.33% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.49% | -133.60% | 423.44% | 741.55% | 1,311.63% |